Hypomethylation of 111 Probes Predicts Poor Prognosis for Glioblastoma

Glioblastoma (GBM) is a complicated brain tumor with heterogeneous outcome. Identification of effective biomarkers is an urgent need for the treatment decision-making and precise evaluation of prognosis. Based on a relatively large dataset of genome-wide methylation (138 glioblastoma patients), a jo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Neurosci
Autors principals: Chen, Qi, Zhao, Min, Yin, Chengliang, Feng, Shiyu, Hu, Jian, Zhang, Qiang, Ma, Xiaodong, Xue, Wanguo, Shi, Jinlong
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Neuroscience
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6823878/
https://ncbi.nlm.nih.gov/pubmed/31708732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnins.2019.01137
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars